Mylan Denied Invalidity In Cancer Drug IP Battle
A Delaware federal judge Tuesday found in favor of Genentech Inc., Pfizer Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals Inc. in their patent infringement suit against Mylan Pharmaceuticals Inc. over...To view the full article, register now.
Already a subscriber? Click here to view full article